Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia.
EBioMedicine(2019)
Abstract
These data demonstrate durable functional benefit of hMUT mRNA and support development of this new class of therapy for a devastating, pediatric disorder. FUND: This work was funded by Moderna, Inc.
MoreTranslated text
Key words
Enzyme replacement,Liver targeted therapy,Methylmalonyl-CoA mutase,Organic acidemia,Systemic mRNA therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined